MV Capital Management’s AC Immune ACIU Stock Holding History

MV Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,340	Closed	-$9K	–	690
2021 Q3	$9K	Buy	+1,340	New	+$9.59K	﹤0.01%	438

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

MV Capital Management's ACIU Position: Q4 2021 in Review

MV Capital Management sold out of AC Immune (ACIU) in Q4 2021, closing a stake of 1,340 shares — an estimated $9K sold.

MV Capital Management first reported a position in ACIU in Q3 2021 and held it in 1 quarter. The position peaked at $9K in Q3 2021. 44 funds tracked by Wall St. Rank hold ACIU as of Q4 2021.

MV Capital Management reported no remaining AC Immune position as of Q4 2021 after selling out during the quarter.
MV Capital Management sold 1,340 AC Immune shares in Q4 2021, an estimated $9K.
MV Capital Management first reported a position in AC Immune in Q3 2021 and held it in 1 quarter.
MV Capital Management's AC Immune position peaked at $9K in Q3 2021.
44 funds tracked by Wall St. Rank held AC Immune as of Q4 2021.

Based on MV Capital Management's 13F filing for Q4 2021, filed 2 Feb 2022.